Retour Accueil 39 Carnot

Carnot AP-HP

Web site Download the sheet
CARNOT AP-HP
Structurer un pôle d’accélération de la recherche partenariale avec les entreprises engagées dans l’innovation

Carnot AP-HP relies on AP-HP, the first University Hospital Center in Europe, to structure a center to accelerate partnership research with companies engaged in innovation. Carnot AP-HP has renowned experts, a comprehensive research and development ecosystem, as well as a governance that is committed to deadlines allowing short and agile processes. Carnot AP-HP is offering industrial players solutions in applied and clinical research across the entire healthcare spectrum.

Key figures
Fermer

Key figures

Permanent staff (full-time equivalent) 3370
PhD Students 1290
Global budget 90 M€
Partnership incomes with industry 42,5 M€
Contact
Fermer

Contact

Institut Carnot AP-HP
Direction de la Recherche Clinique et de l’Innovation (DRCI) de l’AP-HP
Carré Historique de l’Hôpital Saint-Louis, porte 23
1, avenue Claude Vellefaux
75475 PARIS Cedex 10


Pauline CREPEL
AP-HP Carnot  Coordinator
+33 (0)1 44 84 17 61

Email contact
pauline.crepel[a]aphp.fr
Parent institutions

Présentation

Key player in health research in Europe
 

  • 1st University hospital (10 million patients/year)
  • 7.5 billion Euros annual budget
  • 1st clinical trials promoter in Europe
  • 10% of public hospitalization in France
  • 40% of clinical research in France
  • 8,390 publications of which 24% ranked A in 2018

Orientation towards Partnership Research

  • 320 R&D contracts in 2019, including 62 partnership research with an industrial partner
  • 653 patent portfolios (1/3 already licensed)
  • 10% of public valorization revenue in France (24M Euros in 2019)
  • 17 drugs and medical devices on the market:
    • 3 Marketing Authorizations since 2018,
    • 2 Marketing Authorizations in progress (FDA)

Clinical Studies and Translational Research Solutions

  • Feasibility studies and clinical trials set up
  • Clinical and medico-economic evaluation of medical devices
  • e-cohort and real-life study
  • Pharmaceutical development
  • Algorithms development

The Value share of Carnot AP-HP

  • European leader in clinical and translational research
  • Renowned experts in all specialties
  • Complete ecosystem (1st European health data warehouse, registers, cohorts, biological collections, research platforms, etc.) and connected to its partners
  • A dedicated structure and governance integrating industrial partners with performance commitments (deadlines)
  • A new institute to complement the other Carnots

Technological platforms:

  • The Pharmaceutical R&D Department (General Agency for Equipment & Health Products AGEPS)
  • The AP-HP Health Data Warehouse (EDS)
  • MEARY, the production center for Medicines for Innovative Therapies
  • APHP’s Biobank for Intestinal Microbiota Research (BARM)
  • AP-HP Pharmacoepidemiology Center (CEPHEPI)
  • Digital Medical Hub (DMH) - Scientific evaluation of connected objects
  • The innovative Biomarkers platform
  • SeqOIA, the genomics platform
  • MOABI, for bioinformatics analysis for diagnostic purposes
  • ComPare, the platform for e-cohorts
  • Lumière for antenatal diagnosis
  • The Human Nutrition Research Center (CRNH)

Addressed Markets

  • Healthcare technologies: Medical devices, e-health and connected devices
  • Medicines: from molecules repositioning to gene and cell therapy
  • Pre-clinical research
  • Clinical study
  • Biotechnology
  • Diagnosis
  • Processing of health data
  • Artificial Intelligence
Imprimer / PDF
Envoyer un email Facebook Linkedin
Gmail Reddit
39 Carnot